Home > Analyse
Actualite financiere : Actualite bourse

Virbac: Oddo BHF downgrades stock

(CercleFinance.com) - Oddo BHF downgrades Virbac shares from 'outperform' to 'neutral' due to 'lack of momentum', reducing its target price from E414 to E365, in the wake of a reduction in its 2025-26 guidance following the publication of annual sales.


The general impression is that 2024 execution was good, but that 2025 will almost be a transition year: lower price effect, slower growth, consolidation of operating margin, arrival of a new CEO..., the analyst believes.

While acknowledging that valuation multiples have fallen for the animal health group, Oddo BHF considers that momentum appears more limited - excluding acquisitions - and that the share 'could well remain capped'.


Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.